Related Experiment Videos

Intraoperative localization of the sentinel node in breast cancer: technical aspects of lymphoscintigraphic methods

C De Cicco1, M Chinol, G Paganelli

  • 1Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy.

Insights

Sentinel node biopsy using lymphoscintigraphy and a gamma-detecting probe accurately identifies breast cancer spread. This method offers a high concordance rate with traditional axillary dissection, improving staging accuracy.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Nuclear Medicine

Background:

  • Axillary lymph node dissection is crucial for breast cancer staging.
  • Early detection leads to more negative lymph node dissections.
  • Sentinel node biopsy offers a less invasive alternative for staging.

Purpose of the Study:

  • To evaluate the accuracy of lymphoscintigraphy (LS) and radioguided biopsy for sentinel node (SN) identification in breast cancer patients.
  • To compare the effectiveness of LS with blue dye in SN localization.

Main Methods:

  • 382 operable breast cancer patients underwent LS using 99mTechnetium-labeled colloid particles.
  • Sentinel nodes were localized using a gamma-detecting probe (GDP) and surgically removed.
  • Blue dye was used in 54 patients for comparison.

Main Results:

  • LS identified at least one SN in 98.7% of cases.
  • SN localization and removal accuracy was 97.1%.
  • GDP achieved 100% SN localization, while blue dye identified SN in 68.5% of cases.

Conclusions:

  • LS and GDP-guided surgery accurately identify and remove sentinel nodes in breast cancer.
  • Large-size radiolabeled colloids in small volumes enhance SN localization.
  • This technique provides a high concordance rate with traditional axillary dissection.

Related Concept Videos